POET Technologies Inc. (TSXV: PTK and OTCQX: POETF) has designed a revolutionary new device and method that combines electronic and optical components into a single chip-scale package that generates and detects light for fiber-optic networks. The “POET Optical Interposer” (“POI”), lowers costs and improves performance dramatically compared to other approaches. Optoelectronic devices built using the POI are produced hundreds or thousands at a time at wafer-scale, rather than one at a time, using 90% less labor and capital equipment for the same output. POET’s technology was confirmed by one of the world’s largest network systems companies. To add manufacturing capability, POET recently signed a definitive Joint Venture Agreement worth US$50M with Sanan IC, located in Xiamen. San’an Optoelectronics Co. Ltd. (600703.SS) produces over half the world’s LEDs. With products designed by POET, the JV will go into mass production for the data center transceiver market by mid-2021. Other high-growth markets for POET’s technology include optoelectronic devices for Artificial Intelligence (AI), the Internet of Things (IoT), autonomous vehicles and high-speed networking for cloud and enterprise data centers. POET is headquartered in Toronto, with operations in Allentown (Pennsylvania, USA), Singapore and Xiamen. More information may be obtained at www.poet-technologies.com.
Executive Vice President and Chief Financial Officer
Thomas Mika joined POET in November 2016 as CFO, adding the title of Executive Vice President in 2017. Mika previously served as the Chairman & CEO of Tegal Corporation, a semiconductor capital equipment company. On the Board of Directors of Tegal since its spin-out from Motorola in 1989, Mika assumed the roles of Chief Financial Officer in 2002, CEO in 2005 and Chairman & CEO in 2006, positions which he held until 2015. In 2015, Tegal renamed CollabRx Inc. merged with Rennova Health with Mika retaining the position of Chairman until joining POET. Previously, Mika co-founded IMTEC, a boutique investment and consulting firm, serving clients in the U.S., Europe and Japan over a period of 20 years, taking on the role of CEO in several ventures. Earlier in his career, Mika was a managing consultant with Cresap, McCormick & Paget and a policy analyst for the National Science Foundation. He holds a Bachelor of Science in Microbiology from the University of Illinois at Urbana-Champaign and a Master of Business Administration from the Harvard Graduate School of Business.